Drug intelligence / Profile preview

111In-DTPA-IL1RAP

Development stage
Preclinical
Lead developer
Centre Georges-François Leclerc
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals, Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

111In-DTPA-IL1RAP is a radiopharmaceutical imaging probe consisting of an anti-interleukin-1 receptor accessory protein (IL-1RAP) monoclonal antibody (clone B-L43) conjugated with diethylene triamine pentaacetic acid (DTPA) and radiolabeled with the gamma-emitting radionuclide Indium-111 (111In). Developed as a theranostic agent, 111In-DTPA-IL1RAP is designed for single-photon emission computed tomography (SPECT) imaging to detect IL-1RAP-positive hematological malignancies, such as acute myeloid leukemia (AML). It serves as a companion diagnostic to select patients and monitor target expression for anti-IL-1RAP chimeric antigen receptor (CAR) T-cell therapies.

Other names
111In-DTPA-IL-1RAP111In-IL1RAPIndium-111 DTPA-IL1RAPIndium111 DTPA-IL1RAPIndium 111 DTPA-IL1RAP
02

Targets

IL1RAP (Interleukin 1 receptor accessory protein)

Beyond the preview

Go deeper on 111In-DTPA-IL1RAP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 111In-DTPA-IL1RAP.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call